Xeris Pharmaceuticals Inc reported $11.06M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.86M 1.42M
Acura Pharmaceuticals ACUR:US 613K 31K
Eli Lilly And LLY:US $ 6772.8M 32.7M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Horizon Pharma HZNP:US $ 1036.99M 204.44M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Perrigo Ordinary Shares PRGO:US $ 1042.7M 61.6M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
Zogenix ZGNX:US $ 22.61M 3.82M